glp-1 bulimia Therapy: An Emerging Tool in Psychiatry Neurobiological Mechanisms and Therapeutic Potential

A recent trial on the treatment effect of semaglutide in people with obesity reported the significant effects of the long-acting GLP-1RA semaglutide on body weight and related phenotypes (169)

Semaglutide (marketed as 'Ozempic' and 'Wegovy') and the dual-agonist Tirzepatide ('Mounjaro' and 'Zepbound') are some of today's most talked-about medications, given their unprecedented clinical efficacies across both weight loss and T2D management

It targets two of the same three receptors as Retatrutide

Additionally, Tirzepatide has been proven to lower the risk of major cardiovascular events in individuals with type 2 diabetes and other related health conditions

however, this reflects the early stage of research in this field

La disponibilidad de semaglutida oral puede ayudar a ampliar las opciones de tratamiento y facilitar la adopcin de un tratamiento ms precoz con arGLP-1 en el manejo de la DM2